Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeline S Andrew

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Epilepsy & Behavior : E&B|February 2, 2020
Antiepileptic drug effects on subjective and objective cognitionRobert J Quon, Morgan T Mazanec, Samantha S Schmidt, et al.
Genetic Epidemiology|August 2, 2008
A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reductionKristine A Pattin, Bill C White, Nate Barney, et al.
International Journal of Cancer|January 6, 2015
Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrenceAngeline S Andrew, Carmen J Marsit, Alan R Schned, et al.
Muscle & Nerve|January 10, 2018
Toenail mercury Levels are associated with amyotrophic lateral sclerosis riskAngeline S Andrew, Celia Y Chen, Tracie A Caller, et al.
Journal of Neuro-Oncology|June 26, 2020
Molecular genetic profiling reveals novel association between FLT3 mutation and survival in gliomaKevin Shee, Meagan Chambers, Edward G Hughes, et al.
Carcinogenesis|November 29, 2005
Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibilityAngeline S Andrew, Heather H Nelson, Karl T Kelsey, et al.
NPJ Parkinson'S Disease|January 5, 2021
Plasma-borne indicators of inflammasome activity in Parkinson's disease patientsFaith L Anderson, Katharine M von Herrmann, Angeline S Andrew, et al.
Journal of Neurology|July 17, 2017
Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS)Thomas Kuczmarski, Elijah W Stommel, Kristen Riley, et al.
American Journal of Epidemiology|January 6, 2007
Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damageMargaret R Karagas, Michael S Zens, Heather H Nelson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 25, 2020
Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. studyAngeline S Andrew, Katie M O'Brien, Brian P Jackson, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Epilepsy & Behavior : E&B|February 2, 2020
Antiepileptic drug effects on subjective and objective cognitionRobert J Quon, Morgan T Mazanec, Samantha S Schmidt, et al.
Genetic Epidemiology|August 2, 2008
A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reductionKristine A Pattin, Bill C White, Nate Barney, et al.
International Journal of Cancer|January 6, 2015
Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrenceAngeline S Andrew, Carmen J Marsit, Alan R Schned, et al.
Muscle & Nerve|January 10, 2018
Toenail mercury Levels are associated with amyotrophic lateral sclerosis riskAngeline S Andrew, Celia Y Chen, Tracie A Caller, et al.
Journal of Neuro-Oncology|June 26, 2020
Molecular genetic profiling reveals novel association between FLT3 mutation and survival in gliomaKevin Shee, Meagan Chambers, Edward G Hughes, et al.
Carcinogenesis|November 29, 2005
Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibilityAngeline S Andrew, Heather H Nelson, Karl T Kelsey, et al.
NPJ Parkinson'S Disease|January 5, 2021
Plasma-borne indicators of inflammasome activity in Parkinson's disease patientsFaith L Anderson, Katharine M von Herrmann, Angeline S Andrew, et al.
Journal of Neurology|July 17, 2017
Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS)Thomas Kuczmarski, Elijah W Stommel, Kristen Riley, et al.
American Journal of Epidemiology|January 6, 2007
Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damageMargaret R Karagas, Michael S Zens, Heather H Nelson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 25, 2020
Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. studyAngeline S Andrew, Katie M O'Brien, Brian P Jackson, et al.
Pageof 14